Corvus Pharmaceuticals CRVS
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 7.70 | 61 | -18.53 | -12 | -16.26 | 71 |
| 2025Q3 | 7.37 | 72 | -13.36 | -10 | -11.95 | 80 |
| 2025Q2 | 4.00 | 80 | -12.35 | -8 | -10.74 | 89 |
| 2025Q1 | 3.18 | 49 | 37.10 | 15 | 23.68 | 59 |
| 2024Q4 | 5.35 | 33 | -53.86 | -12 | -18.97 | 69 |
| 2024Q3 | 5.28 | 12 | -126.40 | -40 | -65.19 | 59 |
| 2024Q2 | 1.82 | 51 | -10.08 | -4 | -8.15 | 65 |
| 2024Q1 | 1.78 | 33 | -15.83 | -6 | -13.31 | 40 |
| 2023Q4 | 1.76 | 39 | -16.04 | -7 | -13.65 | 46 |
| 2023Q3 | 1.46 | 44 | -12.80 | -6 | -10.91 | 52 |
| 2023Q2 | 2.29 | 49 | -13.22 | -7 | -11.19 | 58 |
| 2023Q1 | 0.91 | 49 | -15.00 | -8 | -12.45 | 58 |
| 2022Q4 | 0.85 | 56 | -16.25 | -10 | -13.21 | 68 |
| 2022Q3 | 0.82 | 65 | -20.45 | -15 | -17.16 | 80 |
| 2022Q2 | 0.99 | 80 | -9.83 | -8 | -8.63 | 93 |
| 2022Q1 | 1.64 | 90 | -8.88 | -8 | -7.87 | 101 |
| 2021Q4 | 2.41 | 97 | -9.13 | -9 | -8.07 | 109 |
| 2021Q3 | 4.84 | 105 | -10.59 | -11 | -9.33 | 119 |
| 2021Q2 | 2.67 | 96 | -12.32 | -12 | -10.75 | 109 |
| 2021Q1 | 3.08 | 94 | -13.91 | -12 | -11.89 | 109 |